Breaking News Instant updates and real-time market news.

CFX

Colfax

$39.58 /

+0.78 (+2.01%)

19:06
01/19/21
01/19
19:06
01/19/21
19:06

Colfax unit DJO acquires Trilliant SUrgical

DJO, LLC, a subsidiary of Colfax Corporation announced the acquisition of Trilliant Surgical, a national provider of foot and ankle orthopedic implants. The acquisition of Trilliant Surgical's "leading product technologies and clinical efficacy supports DJO's focused expansion into the adjacent high-growth $1B US foot and ankle market."

CFX Colfax
$39.58 /

+0.78 (+2.01%)

01/13/21 Deutsche Bank
Colfax named 'Catalyst Call: Sell Idea' at Deutsche Bank
11/18/20 KeyBanc
Colfax price target raised to $44 from $36 at KeyBanc
11/09/20 UBS
Colfax upgraded to Buy from Neutral at UBS
09/15/20 UBS
Colfax initiated with a Neutral at UBS

TODAY'S FREE FLY STORIES

Hot Stocks
LPL Financial announces proposed leverage-neutral transaction » 07:50
03/04/21
03/04
07:50
03/04/21
07:50
LPLA

LPL Financial

$134.56 /

-0.2 (-0.15%)

LPL Financial Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPLA LPL Financial
$134.56 /

-0.2 (-0.15%)

LPLA LPL Financial
$134.56 /

-0.2 (-0.15%)

02/08/21 Citi
LPL Financial price target raised to $203 from $171.50 at Citi
01/12/21 Barclays
LPL Financial price target raised to $130 from $110 at Barclays
01/04/21 Wells Fargo
LPL Financial price target raised to $122 from $110 at Wells Fargo
12/18/20 Compass Point
LPL Financial price target raised to $112 from $85 at Compass Point
LPLA LPL Financial
$134.56 /

-0.2 (-0.15%)

Recommendations
Snowflake price target raised to $270 from $265 at Morgan Stanley » 07:48
03/04/21
03/04
07:48
03/04/21
07:48
SNOW

Snowflake

$246.86 /

-23.73 (-8.77%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

07:05 Today Barclays
Snowflake price target lowered to $270 from $295 at Barclays
06:31 Today Citi
Snowflake price target lowered to $295 from $325 at Citi
06:10 Today Deutsche Bank
Snowflake upgraded to Buy with $300 price target at Deutsche Bank
06:03 Today Deutsche Bank
Snowflake upgraded to Buy from Hold at Deutsche Bank
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

  • 16
    Sep
SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

SNOW Snowflake
$246.86 /

-23.73 (-8.77%)

Hot Stocks
Aurora Mobile partners with Segway-Ninebot to promote smart mobility services » 07:48
03/04/21
03/04
07:48
03/04/21
07:48
JG

Aurora Mobile

$5.68 /

-0.31 (-5.18%)

Aurora Mobile announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JG Aurora Mobile
$5.68 /

-0.31 (-5.18%)

JG Aurora Mobile
$5.68 /

-0.31 (-5.18%)

JG Aurora Mobile
$5.68 /

-0.31 (-5.18%)

Periodicals
Walmart's Flipkart eyes U.S. listing via SPAC merger, Bloomberg reports » 07:47
03/04/21
03/04
07:47
03/04/21
07:47
WMT

Walmart

$127.55 /

-2.54 (-1.95%)

Walmart's Flipkart…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$127.55 /

-2.54 (-1.95%)

WMT Walmart
$127.55 /

-2.54 (-1.95%)

02/23/21 Evercore ISI
Walmart accelerating change with investments, says Evercore ISI
02/19/21 Morgan Stanley
Walmart terminal value rising with investments, says Morgan Stanley
02/19/21 Cowen
Walmart weakness a buying opportunity, says Cowen
02/19/21 Deutsche Bank
Walmart price target lowered to $166 from $170 at Deutsche Bank
WMT Walmart
$127.55 /

-2.54 (-1.95%)

WMT Walmart
$127.55 /

-2.54 (-1.95%)

WMT Walmart
$127.55 /

-2.54 (-1.95%)

WMT Walmart
$127.55 /

-2.54 (-1.95%)

General news
Treasury Market Outlook: stocks are broadly lower » 07:45
03/04/21
03/04
07:45
03/04/21
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Dick's Sporting price target raised to $75 from $64 at UBS » 07:45
03/04/21
03/04
07:45
03/04/21
07:45
DKS

Dick's Sporting

$72.40 /

-0.62 (-0.85%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$72.40 /

-0.62 (-0.85%)

DKS Dick's Sporting
$72.40 /

-0.62 (-0.85%)

02/16/21 Cowen
Dick's Sporting price target raised to $87 from $81 at Cowen
02/05/21 Gordon Haskett
Dick's Sporting initiated with a Hold at Gordon Haskett
01/27/21
Fly Intel: Top five analyst upgrades
01/27/21 Citi
Dick's Sporting upgraded to Buy from Neutral at Citi
DKS Dick's Sporting
$72.40 /

-0.62 (-0.85%)

DKS Dick's Sporting
$72.40 /

-0.62 (-0.85%)

DKS Dick's Sporting
$72.40 /

-0.62 (-0.85%)

Hot Stocks
Tonix Pharmaceuticals regains compliance with Nasdaq minimum price rule » 07:44
03/04/21
03/04
07:44
03/04/21
07:44
TNXP

Tonix Pharmaceuticals

$1.12 /

-0.09 (-7.44%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$1.12 /

-0.09 (-7.44%)

TNXP Tonix Pharmaceuticals
$1.12 /

-0.09 (-7.44%)

02/25/21 Alliance Global Partners
Tonix price target raised to $4 from $3 at Alliance Global Partners
12/21/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Aptinyx after competitor fails in PTSD
08/20/20 Alliance Global Partners
Tonix price target raised to $3 from $2.50 at Alliance Global Partners
TNXP Tonix Pharmaceuticals
$1.12 /

-0.09 (-7.44%)

Hot Stocks
Genetic Technologies signs multi-year distribution agreement for COVID Risk Test » 07:44
03/04/21
03/04
07:44
03/04/21
07:44
GENE

Genetic Technologies

$4.50 /

+0.09 (+2.04%)

Genetic Technologies is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GENE Genetic Technologies
$4.50 /

+0.09 (+2.04%)

GENE Genetic Technologies
$4.50 /

+0.09 (+2.04%)

Hot Stocks
Wipro to acquire Capco » 07:42
03/04/21
03/04
07:42
03/04/21
07:42
WIT

Wipro

$6.47 /

+0.005 (+0.08%)

Wipro announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WIT Wipro
$6.47 /

+0.005 (+0.08%)

WIT Wipro
$6.47 /

+0.005 (+0.08%)

12/21/20 Goldman Sachs
Wipro resumed with a Sell at Goldman Sachs
10/14/20 Investec
Wipro downgraded to Hold from Buy at Investec
10/06/20 ICICI Securities
Wipro downgraded to Hold from Buy at ICICI Securities
07/16/20 Wedbush
Infosys upgraded to Outperform on improving visibility at Wedbush
WIT Wipro
$6.47 /

+0.005 (+0.08%)

Syndicate
nLight 2.206M share Spot Secondary priced at $34.00 » 07:42
03/04/21
03/04
07:42
03/04/21
07:42
LASR

nLight

$36.79 /

-0.93 (-2.47%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LASR nLight
$36.79 /

-0.93 (-2.47%)

02/18/21 DA Davidson
nLight price target raised to $48 from $30 at DA Davidson
02/18/21 Craig-Hallum
nLight price target raised to $48 from $32 at Craig-Hallum
02/18/21 Canaccord
nLight price target raised to $53 from $27 at Canaccord
01/21/21 Berenberg
nLight assumed with a Hold at Berenberg
LASR nLight
$36.79 /

-0.93 (-2.47%)

  • 04
    Mar
LASR nLight
$36.79 /

-0.93 (-2.47%)

Downgrade
WSFS Financial downgraded to Neutral from Outperform at Boenning & Scattergood » 07:41
03/04/21
03/04
07:41
03/04/21
07:41
WSFS

WSFS Financial

$51.90 /

+0.68 (+1.33%)

Boenning &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSFS WSFS Financial
$51.90 /

+0.68 (+1.33%)

WSFS WSFS Financial
$51.90 /

+0.68 (+1.33%)

03/01/21 Piper Sandler
WSFS Financial downgraded to Neutral from Overweight at Piper Sandler
02/25/21 Keefe Bruyette
WSFS Financial downgraded to Market Perform from Outperform at Keefe Bruyette
04/01/20 Keefe Bruyette
WSFS Financial upgraded to Outperform from Market Perform at Keefe Bruyette
WSFS WSFS Financial
$51.90 /

+0.68 (+1.33%)

WSFS WSFS Financial
$51.90 /

+0.68 (+1.33%)

Hot Stocks
Skylight Health to acquire three U.S. primary care practices » 07:41
03/04/21
03/04
07:41
03/04/21
07:41
SHGFF

Skylight Health

$0.00 /

+ (+0.00%)

Skylight Health Group is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHGFF Skylight Health
$0.00 /

+ (+0.00%)

SHGFF Skylight Health
$0.00 /

+ (+0.00%)

02/24/21 Raymond James
Skylight Health initiated with an Outperform at Raymond James
Hot Stocks
Dyne Therapeutics expects cash to fund requirements into 2H24 » 07:40
03/04/21
03/04
07:40
03/04/21
07:40
DYN

Dyne Therapeutics

$16.73 /

-1.02 (-5.75%)

In January 2021, Dyne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

02/09/21
Dyne Therapeutics initiated with a Buy at JonesTrading
01/07/21 Piper Sandler
Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper
10/12/20 Jefferies
Dyne Therapeutics initiated with a Buy at Jefferies
10/12/20 JPMorgan
Dyne Therapeutics initiated with an Overweight at JPMorgan
DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

  • 21
    Jan
  • 17
    Sep
DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

Earnings
Dyne Therapeutics reports Q4 EPS (64c), consensus (37c) » 07:39
03/04/21
03/04
07:39
03/04/21
07:39
DYN

Dyne Therapeutics

$16.73 /

-1.02 (-5.75%)

"2020 was a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

02/09/21
Dyne Therapeutics initiated with a Buy at JonesTrading
01/07/21 Piper Sandler
Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper
10/12/20 Jefferies
Dyne Therapeutics initiated with a Buy at Jefferies
10/12/20 JPMorgan
Dyne Therapeutics initiated with an Overweight at JPMorgan
DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

  • 21
    Jan
  • 17
    Sep
DYN Dyne Therapeutics
$16.73 /

-1.02 (-5.75%)

Hot Stocks
Arbutus Biopharma sees cash runway into 3Q22 » 07:38
03/04/21
03/04
07:38
03/04/21
07:38
ABUS

Arbutus Biopharma

$3.64 /

-0.19 (-4.97%)

Arbutus had cash, cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
07/27/20 B. Riley FBR
Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR
07/24/20 Baird
Arbutus Biopharma upside priced in, Baird downgrades to Neutral
ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

Initiation
Histogen initiated with a Buy at Canaccord » 07:38
03/04/21
03/04
07:38
03/04/21
07:38
HSTO

Histogen

$1.15 /

-0.035 (-2.95%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSTO Histogen
$1.15 /

-0.035 (-2.95%)

  • 31
    Dec
HSTO Histogen
$1.15 /

-0.035 (-2.95%)

Earnings
Arbutus Biopharma reports 2020 EPS ($1.00), consensus (98c) » 07:38
03/04/21
03/04
07:38
03/04/21
07:38
ABUS

Arbutus Biopharma

$3.64 /

-0.19 (-4.97%)

Reports 2020 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
07/27/20 B. Riley FBR
Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR
07/24/20 Baird
Arbutus Biopharma upside priced in, Baird downgrades to Neutral
ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

ABUS Arbutus Biopharma
$3.64 /

-0.19 (-4.97%)

Hot Stocks
Dicerna, Roche begin combo trial of GalXC for chronic HBV treatment » 07:37
03/04/21
03/04
07:37
03/04/21
07:37
DRNA

Dicerna

$29.00 /

-0.52 (-1.76%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Dicerna Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRNA Dicerna
$29.00 /

-0.52 (-1.76%)

RHHBY Roche
$0.00 /

+ (+0.00%)

DRNA Dicerna
$29.00 /

-0.52 (-1.76%)

03/02/21 H.C. Wainwright
Dicerna price target raised to $40 from $35 at H.C. Wainwright
03/02/21 Chardan
Dicerna price target raised to $34 from $25 at Chardan
03/01/21 B. Riley Securities
Dicerna price target raised to $40 from $37 at B. Riley Securities
01/11/21 B. Riley Securities
Dicerna price target raised to $37 from $30 at B. Riley Securities
RHHBY Roche
$0.00 /

+ (+0.00%)

03/03/21 Goldman Sachs
Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
02/25/21 Berenberg
Roche price target lowered to CHF 320 from CHF 325 at Berenberg
02/24/21 Morgan Stanley
Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
DRNA Dicerna
$29.00 /

-0.52 (-1.76%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

DRNA Dicerna
$29.00 /

-0.52 (-1.76%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Upgrade
Agricultural Bank of China upgraded to Buy from Neutral at Goldman Sachs » 07:37
03/04/21
03/04
07:37
03/04/21
07:37
ACGBY

Agricultural Bank of China

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACGBY Agricultural Bank of China
$0.00 /

+ (+0.00%)

04/03/20 Jefferies
Agricultural Bank of China initiated with a Buy at Jefferies
Hot Stocks
Verrica Pharmaceuticals expects cash to support operations at least into 1Q22 » 07:36
03/04/21
03/04
07:36
03/04/21
07:36
VRCA

Verrica Pharmaceuticals

$15.18 /

+0.97 (+6.83%)

As of December 31, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

12/24/20 Cowen
Verrica approval for molluscum likely in Q3 of 2021, says Cowen
12/24/20 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright
07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

Upgrade
Canaccord upgrades Okta to Buy on recent selloff, accretive acquisition » 07:36
03/04/21
03/04
07:36
03/04/21
07:36
OKTA

Okta

$242.42 /

-16.595 (-6.41%)

Canaccord analyst T.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$242.42 /

-16.595 (-6.41%)

OKTA Okta
$242.42 /

-16.595 (-6.41%)

06:53 Today Deutsche Bank
Okta price target lowered to $270 from $313 at Deutsche Bank
06:45 Today Mizuho
Okta price target lowered to $255 from $305 at Mizuho
06:37 Today Baird
Okta price target lowered to $240 from $275 at Baird
06:06 Today Piper Sandler
Okta price target lowered to $235 from $250 at Piper Sandler
OKTA Okta
$242.42 /

-16.595 (-6.41%)

OKTA Okta
$242.42 /

-16.595 (-6.41%)

OKTA Okta
$242.42 /

-16.595 (-6.41%)

Hot Stocks
Verrica says Torii exercises option to acquire license for VP-102 » 07:35
03/04/21
03/04
07:35
03/04/21
07:35
VRCA

Verrica Pharmaceuticals

$15.18 /

+0.97 (+6.83%)

On March 2, Torii…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

12/24/20 Cowen
Verrica approval for molluscum likely in Q3 of 2021, says Cowen
12/24/20 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright
07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

Upgrade
Postal Savings Bank of China upgraded to Conviction Buy at Goldman Sachs » 07:34
03/04/21
03/04
07:34
03/04/21
07:34
PSTVY

Postal Savings Bank of China

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Verrica Pharmaceuticals resubmits NDA for VP-102 » 07:34
03/04/21
03/04
07:34
03/04/21
07:34
VRCA

Verrica Pharmaceuticals

$15.18 /

+0.97 (+6.83%)

The Company recently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

12/24/20 Cowen
Verrica approval for molluscum likely in Q3 of 2021, says Cowen
12/24/20 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright
07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
VRCA Verrica Pharmaceuticals
$15.18 /

+0.97 (+6.83%)

Earnings
Syros Pharmaceuticals reports Q4 EPS (62c), consensus (50c) » 07:33
03/04/21
03/04
07:33
03/04/21
07:33
SYRS

Syros Pharmaceuticals

$8.33 /

-0.87 (-9.46%)

Reports Q4 revenue $5.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$8.33 /

-0.87 (-9.46%)

SYRS Syros Pharmaceuticals
$8.33 /

-0.87 (-9.46%)

11/10/20 Brookline
Syros Pharmaceuticals initiated with a Buy at Brookline
11/05/20 Roth Capital
Syros' SY-1425+Aza could be competitive in multiple settings, says Roth Capital
11/04/20
Fly Intel: Top five analyst upgrades
11/04/20 H.C. Wainwright
Syros Pharmaceuticals upgraded to Buy from Neutral at H.C. Wainwright
SYRS Syros Pharmaceuticals
$8.33 /

-0.87 (-9.46%)

  • 20
    Jan
SYRS Syros Pharmaceuticals
$8.33 /

-0.87 (-9.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.